Seeing Is Believing
AMGN is currently covered by 25 analysts with an average price target of $325.41. This is a potential upside of $31.02 (10.54%) from yesterday's end of day stock price of $294.39.
Amgen's activity chart (see below) currently has 508 price targets and 469 ratings on display. The stock rating distribution of AMGN is 10.75% SELL, 36.56% HOLD and 52.69% BUY.
Analysts average stock forecasts to be materialized ratio is 87.36% with an average time for these price targets to be met of 573.29 days.
Highest price target for AMGN is $380, Lowest price target is $215, average price target is $306.86.
Most recent stock forecast was given by TIM ANDERSON from BAML on 05-Mar-2025.
Amgen is a biotechnology company that specializes inĀ developing, manufacturing, and delivering human therapeutics.
The company’s research focuses on six main therapeutic areas, which include inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.
Amgen produces drugs such as Enbrel, Neulasta, Prolia, Xgeva, Aranesp, KYPROLIS, and Repatha, which treat anemia, cardiovascular disease, multiple myeloma, osteoporosis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.
Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.
Currently out of the existing stock ratings of AMGN, 10 are a SELL (10.75%), 34 are a HOLD (36.56%), 49 are a BUY (52.69%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$294
$-12.95 (-4.22%)
$275
30 days ago
(05-Mar-2025)
2/5 (40%)
$-18.19 (-5.83%)
124
Buy
$329
$22.05 (7.18%)
$310
1 months 25 days ago
(10-Feb-2025)
1/2 (50%)
$34.21 (11.60%)
54
Hold
$295
$-11.95 (-3.89%)
$335
2 months 7 days ago
(28-Jan-2025)
8/9 (88.89%)
$14.7 (5.24%)
563
Buy
$324
$17.05 (5.55%)
$324
2 months 11 days ago
(24-Jan-2025)
12/15 (80%)
$48.58 (17.64%)
75
Hold
$280
$-26.95 (-8.78%)
$335
2 months 25 days ago
(10-Jan-2025)
7/8 (87.5%)
$17.77 (6.78%)
361
What is AMGN (Amgen) average time for price targets to be met?
Which analyst has the current highest performing score on AMGN (Amgen) with a proven track record?
Which analyst has the most public recommendations on AMGN (Amgen)?
Which analyst is the currently most bullish on AMGN (Amgen)?
Which analyst is the currently most reserved on AMGN (Amgen)?